InvestorsHub Logo
icon url

Shawking

01/22/20 3:53 PM

#27841 RE: Inspector121 #27839

This explains a lot.
Lexaria’s workgroup, including extensive ongoing R&D performed by Canada’s National Research Council on our behalf, continues to work closely with Altria to determine the appropriateness of the DehydraTECH technology for potential use in the global tobacco industry, via several product formats currently under investigation. Lexaria is making important, significant progress in its goal of achieving reduced-risk methods of nicotine delivery.
https://www.lexariabioscience.com/news/lexaria-bioscience-ceo-discusses-strategic-outlook/